prazosin has been researched along with Heroin Abuse in 2 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Park, PE | 1 |
Schlosburg, JE | 1 |
Vendruscolo, LF | 1 |
Schulteis, G | 1 |
Edwards, S | 1 |
Koob, GF | 2 |
Greenwell, TN | 1 |
Walker, BM | 1 |
Cottone, P | 1 |
Zorrilla, EP | 1 |
2 other studies available for prazosin and Heroin Abuse
Article | Year |
---|---|
Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antag | 2015 |
The alpha1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Conditioning, Operant; | 2009 |